Rachel Lenington - COO and CDO at LeonaBio, Inc.

Insider Transactions and Holdings

Identity
Entity type
Individual
Issuer context
SEC evidence

There are no Buy or Sell transactions made by Rachel Lenington since 30 May 2025

Holdings reported by Rachel Lenington for LeonaBio, Inc.

Form 4 holding COO and CDO

Athira Pharma, Inc.

Security class
Common Stock
Shares / value
20,870
Estimated value
$11,812
Report date
05 Sep 2024
Price
$0.5660
Ownership
Direct
Form 4 holding COO and CDO

Athira Pharma, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
300,000
Estimated value
Report date
14 Feb 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transactions reported by Rachel Lenington for LeonaBio, Inc.

Sym Class Transaction % Reported value Reported price Shares Shares after Date Ownership
* indicates a reported price that failed the local validity check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .